The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.2059iti1
The Journal of Experimental Medicine, Vol. 205, No. 9, 1944-
The Rockefeller University Press, 0022-1007 $30.00
© Bashyam
This Article
Right arrow Full Text (PDF, 1060K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

IN THIS ISSUE

Arginine reverses T cell defects


Figure 1
The arginine-destroying enzyme arginase is elevated in the livers of patients with chronic hepatitis B virus infections.

An amino acid might help fight chronic hepatitis, according to a study by Das et al. (page 2111).

The amino acid arginine is indispensible for the host's T cell response against tumors or chronic infection. Without arginine, a T cell receptor (TCR) component cannot be produced efficiently, thus dampening TCR signaling. As a result, the cells do not proliferate normally or produce the survival cytokine IL-2, although they still make inflammatory cytokines such as IFN{gamma} and TNF.

Das et al. now find that CD8+ T cells in the livers of patients with chronic hepatitis B infections show signs of arginine starvation. Despite proliferating poorly, the cells' production of IFN{gamma} and TNF might explain the liver damage seen in these patients. The amino acid deficiency stemmed from the activity of the arginine-destroying enzyme arginase, which was elevated in inflamed livers. The arginase source is still unknown but seems to be confined to the liver, as T cells elsewhere in the patients were less affected.

Culturing patients' liver-derived CD8+ T cells with arginine corrected their defects. Whether arginine supplements can help cure hepatitis B remains to be seen.



Hema Bashyam

hbashyam{at}rockefeller.edu



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 1060K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS